Post Market Surveillance (PMS)

Post-market surveillance is the continuous monitoring of a device’s performance and safety once it’s on the market. It’s a legal requirement under MDR Annex III, designed to ensure manufacturers remain responsible for their products throughout the entire lifecycle.

Effective PMS isn’t just about reacting to complaints; it’s about proactively identifying trends, risks, and opportunities for improvement. A well-structured PMS system can reduce recalls, inform product development, and demonstrate regulatory maturity.

Clinera Solutions develops PMS documentation that transforms compliance into a strategic advantage. We integrate data from vigilance reports, literature, complaints, and user feedback to provide meaningful insights for continuous improvement. All PMS documentation is developed in line with MDCG 2017-1, MDCG 2020-6, and MDR/IVDR Annex III.

Our post market surveillance services include:

  • PMS Plan & Report: defines how post-market data will be collected, analysed, and reported throughout the device’s lifecycle.
  • Periodic Safety Update Report (PSUR): provides a structured summary of PMS data, trends, and benefit–risk evaluation, required for Class IIa, IIb, and III devices.
  • Post-Market Clinical Follow-Up (PMCF) Plan & Report: outlines and reports proactive activities to gather and evaluate clinical data, ensuring the ongoing validity of the CER.

Why choose us?

At Clinera Solutions, expertise is built into every document delivered. Each project benefits from years of hands-on experience in clinical and regulatory writing, with a focus on accuracy, efficiency, and clear clinical storytelling.